EMJ Podcast: Insights For Healthcare Professionals

This week, Jonathan is joined by John ‘Jack’ Cush, Director of Clinical Rheumatology at the Baylor Research Institute, Dallas, Texas, USA. The two doctors explore novel treatment avenues for rheumatic diseases, and discuss the exciting potential of AI and telemedicine. 

Please use the following timestamps to navigate this episode: 

(00:00)-Introduction  

(02:29)-The history of beer and rock’ n roll

(06:10)-Transitioning into digital medical education

(10:21)-Jack’s podcast: RheumNow

(14:30)-Challenges in lupus diagnosis and management

(16:58)-IL-5 inhibitors: novel drugs for allergic vasculitis  

(19:22)-How does diet affect inflammation and bone health?

(24:22)-Telemedicine in rheumatology

(29:26)-Lessons in rheumatoid arthritis care

(33:30)-Soaring costs in healthcare

(36:40)-New horizons in rheumatoid arthritis treatment

(41:37)-The future of AI

(43:30)-Jack’s three wishes for rheumatology

In this bonus episode, join EMJ host Dr Hannah Moir as she speaks with our two health and wellbeing experts, Dr Sula Windgassen and Kiera McGarrity, who provide their expertise and personal experiences of using intermittent catheters. The experts address the emotional impact of intermittent catheter use and provide solutions and practical tools to support and improve patient wellbeing and advance the standard of care.  

This is episode one of a three-part series: Confident Living with Intermittent Catheterisation. 

This podcast was initiated and funded by Convatec. The views and opinions expressed in this podcast are those of the individual speakers and do not necessarily reflect those of Convatec or EMJ. 

In this second instalment Jonathan is joined by Sunil Gupta, Consultant Haematologist and haemato-oncologist based at Lewisham and Greenwich NHS Trust, UK, to delve further into prophylactic anticoagulation in APML patients with COVID-19 and, anthracycline toxicity, and new drug appraisals for NICE.

Timestamps: 

(00:00)-Introduction

(00:25)-Prophylactic anticoagulation in patients with APML

(03:26)-Anthracyclin as the cornerstone of chemotherapy

(08:18)-Developing drugs for cancer

(16:52)-New innovations in haematology

(20:00)-Sunil’s three wishes

Moderated by Sue Saville.

With speakers: Prof Dr Frank Broekmans, Prof Peter Humaidan, Prof Dr Dominic Stoop, Dr Samuel Santos-Ribeiro.

These podcasts were sponsored by Besins Healthcare.

Moderated by Sue Saville.

With speakers: Prof Dr Frank Broekmans, Prof Peter Humaidan, Prof Dr Dominic Stoop, Dr Samuel Santos-Ribeiro.

These podcasts were sponsored by Besins Healthcare.

Moderated by Sue Saville.

With speakers: Prof Dr Frank Broekmans, Prof Peter Humaidan, Prof Dr Dominic Stoop, Dr Samuel Santos-Ribeiro.

These podcasts were sponsored by Besins Healthcare.

Moderated by Sue Saville.

With speakers: Prof Dr Frank Broekmans, Prof Peter Humaidan, Prof Dr Dominic Stoop, Dr Samuel Santos-Ribeiro.

These podcasts were sponsored by Besins Healthcare.

This week, Jonathan is joined by Mandeep Sagoo, Professor of Ophthalmology and Ocular Oncology, UCL Institute of Ophthalmology, London, UK. The pair explore ocular oncology and Mandeep’s groundbreaking work developing a digitally engineered 3D printed ocular prosthetic.  

Use the following timestamps to navigate this episode: 

(00:00)-Introduction

(04:17)-Mandeep’s journey into ophthalmology

(08:06)-Pioneering work in Philadelphia, USA

(11:15)-Lessons from the US healthcare system

(13:30)-Churchill’s Fellow Award

(16:25)-Naevi and the role of ocular coherence tomography

(20:00)-How to diagnose malignancies

(30:38)-Creating prosthetic eyes following enucleation

(34:06)-3D printed prosthetics

(39:28)-Retinoblastoma

(42:45)-Innovations in molecular medicine

(44:42)-Three wishes for ocular oncology

This week, Jonathan is joined by Aniket Mohite, a distinguished member of the EMJ Oncology Editorial Board.  

Timestamps:     

00:00 – Introduction 

01:50 – Dr Aniket Mohite’s background and bio 

02:35 – Dr Mohite’s journey into haematology-oncology: challenges and rewards 

06:15 – How international experience shaped Dr Mohite’s practice 

13:50 – Significant research contributions and impact 

17:40 – Current challenges in haematology and overcoming them 

21:45 – Approaching patient education in haematology-oncology 

28:50 – Discussing initiatives like World Cancer Day and supporting patients and families through cancer 

31:26 – Addressing smoking and its impact on cancer treatment 

36:00 – Emerging diagnostic technologies in haematology 

38:50 – Dr Mohite shares his three wishes for the field of haematology-oncology  

This week, Jonathan is joined by Kyle Richards, Associate Professor of Urology at the University of Wisconsin School of Medicine and Public Health, Madison, USA. The pair explore new treatment approaches for urologic cancers and the importance of patient education and comprehensive care.

Use the following timestamps to navigate this episode:

(00:00)-Introduction 

(02:47)-Ice fishing is Wisconsin

(05:00)-Kyle’s passion for urologic oncology

(07:26)-Advocating for patient education

(11:25)-Agent Orange and bladder cancer

(15:59)-Screening for bladder cancer

(20:19)-The role of BCG in bladder cancer

(24:15)-Prostate cancer diagnosis

(27:12)-Penile cancer

(30:29)-Exciting advancements in the field

(33:30)-Physician led social media

(37:27)-Kyle’s three wishes for healthcare